Daily non-political popular news in brief.
Radiation heart dose from MammoSite compared to IMRT for left-sided breast cancers
11-08-2006 · EurekAlert!When compared to IMRT, MammoSite brachytherapy does not always deliver lower doses of radiation to the heart during treatment of left-sided breast cancers.
Read more »
Keywords: radiation, heart, dose, mammosite, compared, imrt, left-sided, breast, cancers, left, sided, cancer
« Previous | Next »
Similar news on "Radiation heart dose from MammoSite compared to IMRT for left-sided breast cancers":
- Extra radiation dose prevents breast cancer return in young women
10-29-2007 · EurekAlert!
Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation after undergoing breast-conserving surgery and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose.
Similar news · Read more »
- Breast cancer survivors experience long-term heart disease risk from radiotherapy
03-06-2007 · EurekAlert!
Women who were treated with radiation for breast cancer during the 1980s may be at an increased risk for heart disease compared with the general population, according to a new study in the March 7 Journal of the National Cancer Institute. Despite this increased risk of heart disease, radiation therapy has been previously shown to improve the chances of surviving breast cancer.
Similar news · Read more »
- New radiation technique can greatly reduce painful skin burns in women with breast cancer
11-06-2006 · EurekAlert!
Breast cancer patients who undergo a new radiation technique called intensity modulated radiation therapy (IMRT) after surgery are three times less likely to have severe skin reactions from the treatment compared to standard radiation therapy, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia. The study is the first of its kind to show how recent dramatic improvements in radiation treatments directly benefit patients.
Similar news · Read more »
- IMRT better for sparing bladder when treating prostate cancer
10-09-2007 · EurekAlert!
When treating early-stage prostate cancer, intensity modulated radiation therapy spares the bladder significantly more from direct radiation when compared to 3-D conformal proton therapy , but the amount of rectal sparing is similar with both treatments, according to a study released in the October issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
Similar news · Read more »
- Increasing radiation dose shortens treatment time for women who choose breast sparing treatment
05-29-2007 · EurekAlert!
Radiation therapy after lumpectomy for early-stage breast cancer can be safely delivered in higher daily doses to greatly reduce treatment time. This conclusion of a new Fox Chase Cancer Center study is good news for women who might opt to have a mastectomy instead of a lumpectomy because of the time commitment needed for the usual six-week radiation course with the breast-sparing surgical option.
Similar news · Read more »
- Cancer stem cells can go it alone
06-11-2007 · EurekAlert!
At the heart of most, if not all cancers, lie a handful of wayward stem cells that feed the ever growing tumor mass, but their scarcity make it difficult for scientists to study them. Now, times of plenty may lie ahead as a breast cancer cell line -- established long ago -- turned out to behave a lot like cancer stem cells.
Similar news · Read more »
- Normal tissue not spared in new forms of breast cancer radiotherapy
10-30-2007 · EurekAlert!
A five-day course of radiotherapy to treat breast cancer may, in some cases, expose as much lung and heart tissue to potentially toxic radiation as does the standard six weeks of treatment, say researchers at Mayo Clinic Jacksonville.
Similar news · Read more »
- Blocking cancer-causing gene improves radiation effectiveness, Jefferson researchers find
11-08-2006 · EurekAlert!
Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists has found. Using a combination of zebrafish and antisense technology, they've shown that the drug flavopiridol works by blocking the activity of a gene, cyclin D1, which is overexpressed in about half of all breast cancers. Similar techniques in the future, the scientists say, may enable researchers to better gauge the effects of drugs.
Similar news · Read more »
- Cone-Beam CT faster, potentially more accurate than conventional mammography
12-27-2007 · EurekAlert!
Cone-beam breast CT provides exceptional tissue contrast and can potentially reduce examination time with comparable radiation dose to conventional 2D mammography, according to a new study by a team of researchers from the University of Texas M. D. Anderson Cancer Center in Houston.
Similar news · Read more »
- Integrated approach to IMRT provides quality care for head and neck cancer patients
10-28-2007 · EurekAlert!
Results from a University of Pittsburgh study demonstrate that intensity-modulated radiation therapy can be uniformly delivered in a large healthcare system of academic and community cancer centers through a centralized planning and treatment process. According to study results, there were no significant differences in toxicity profiles and recommended radiation dose prescriptions in 604 head and neck cancer patients treated with IMRT at 12 separate community cancer centers and one academic flagship facility.
Similar news · Read more »
